IN8bio Inc (INAB)
0.2858
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
0.30
+0.01
(+4.97%)
After-Hours: 20:00
IN8bio Free Cash Flow: -24.88M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -24.88M |
| March 31, 2024 | -24.06M |
| December 31, 2023 | -23.94M |
| September 30, 2023 | -28.23M |
| June 30, 2023 | -29.94M |
| March 31, 2023 | -30.88M |
| December 31, 2022 | -27.83M |
| September 30, 2022 | -20.95M |
| Date | Value |
|---|---|
| June 30, 2022 | -19.96M |
| March 31, 2022 | -15.56M |
| December 31, 2021 | -13.51M |
| September 30, 2021 | -13.06M |
| June 30, 2021 | -8.817M |
| March 31, 2021 | -8.017M |
| December 31, 2020 | -7.133M |
Free Cash Flow Range, Past 5 Years
-30.88M
Minimum
Mar 2023
-7.133M
Maximum
Dec 2020
-19.78M
Average
-20.95M
Median
Sep 2022
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -3.396M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.55M |
| Theriva Biologics Inc | -18.01M |
| Oragenics Inc | -7.214M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.091M |
| Cash from Investing (Quarterly) | -0.083M |
| Cash from Financing (Quarterly) | 3.379M |
| Free Cash Flow Per Share (Quarterly) | -0.1368 |
| Free Cash Flow Yield | -225.2% |